feed,title,long_url,short_url
Benzinga,Arcutis Stops ARQ-252 Vitiligo Trial After Formulation-Related Observations In Chronic Hand Eczema Study,https://benzinga.com/general/biotech/21/07/21805279/arcutis-stops-arq-252-vitiligo-trial-after-formulation-related-observations-in-chronic-hand-eczem,https://j.mp/3AgjOWd
